Global Patent Index - EP 1328534 A2

EP 1328534 A2 20030723 - 6-O-SUBSTITUTED ERYTHROMYCIN DERIVATIVES HAVING IMPROVED GASTROINTESTINAL TOLERANCE

Title (en)

6-O-SUBSTITUTED ERYTHROMYCIN DERIVATIVES HAVING IMPROVED GASTROINTESTINAL TOLERANCE

Title (de)

6-O SUBSTITUIERTE ERYTHROMYCINDERIVATE MIT VERBESSERTER GASTROINTESTINALE TOLERANZ

Title (fr)

DERIVES D'ERYTHROMYCINE SUBSTITUE EN 6-O POSSEDANT UNE TOLERANCE GASTRO-INTESTINALE AMELIOREE

Publication

EP 1328534 A2 20030723 (EN)

Application

EP 01981637 A 20011016

Priority

  • US 0132278 W 20011016
  • US 24077700 P 20001016

Abstract (en)

[origin: WO0232919A2] Compounds having formula (I) (I) are useful for treating bacterial infections while avoiding the concomitant liability of gastrointestinal intolerance. Compositions containing the compounds and methods of treatment using the compounds are also disclosed.

[origin: WO0232919A2] Compounds having formula (I) are useful for treating bacterial infections while avoiding the concomitant liability of gastrointestinal intolerance. Compositions containing the compounds and methods of treatment using the compounds are also disclosed.

IPC 1-7

C07H 17/08; A61K 31/7048; A61P 31/04

IPC 8 full level

A61K 31/7056 (2006.01); A61P 31/04 (2006.01); C07H 17/08 (2006.01)

CPC (source: EP)

A61P 31/04 (2017.12); C07H 17/08 (2013.01)

Citation (search report)

See references of WO 0232919A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0232919 A2 20020425; WO 0232919 A3 20020919; AU 1326702 A 20020429; BR 0109946 A 20050802; CA 2420012 A1 20020425; EP 1328534 A2 20030723; JP 2004529857 A 20040930; MX PA03003311 A 20030910; PE 20020522 A1 20020625; UY 26964 A1 20020620

DOCDB simple family (application)

US 0132278 W 20011016; AU 1326702 A 20011016; BR 0109946 A 20011016; CA 2420012 A 20011016; EP 01981637 A 20011016; JP 2002536300 A 20011016; MX PA03003311 A 20011016; PE 2001001021 A 20011015; UY 26964 A 20011012